Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 18
1988 11
1989 20
1990 50
1991 41
1992 38
1993 46
1994 42
1995 45
1996 52
1997 61
1998 48
1999 70
2000 61
2001 64
2002 76
2003 57
2004 87
2005 87
2006 82
2007 70
2008 72
2009 74
2010 74
2011 100
2012 50
2013 70
2014 96
2015 59
2016 67
2017 72
2018 71
2019 73
2020 85
2021 64
2022 75
2023 76
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

2,166 results

Results by year

Filters applied: . Clear all
Page 1
Review of cetirizine hydrochloride for the treatment of allergic disorders.
Portnoy JM, Dinakar C. Portnoy JM, et al. Expert Opin Pharmacother. 2004 Jan;5(1):125-35. doi: 10.1517/14656566.5.1.125. Expert Opin Pharmacother. 2004. PMID: 14680442 Review.
Cetirizine hydrochloride is an orally-active and selective histamine (H(1))-receptor antagonist. ...There is evidence that cetirizine improves symptoms of urticaria. Concomitant use of cetirizine also decreases the duration and amount of topical anti-i …
Cetirizine hydrochloride is an orally-active and selective histamine (H(1))-receptor antagonist. ...There is evidence that …
Cetirizine anaphylaxis.
Rutkowski K, Wagner A. Rutkowski K, et al. Ann Allergy Asthma Immunol. 2014 Sep;113(3):247-9. doi: 10.1016/j.anai.2014.06.030. Ann Allergy Asthma Immunol. 2014. PMID: 25168222 No abstract available.
Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Bassiouny EA, El-Samanoudy SI, Abbassi MM, Nada HR, Farid SF. Bassiouny EA, et al. Arch Dermatol Res. 2023 Jul;315(5):1293-1304. doi: 10.1007/s00403-022-02512-2. Epub 2022 Dec 26. Arch Dermatol Res. 2023. PMID: 36571611 Free PMC article. Clinical Trial.
Currently, topical minoxidil is the only FDA-approved treatment for female AGA and it needs life-long application and causes side effects. Cetirizine is an antihistamine that may be effective in hair loss treatment. This study aimed to compare the efficacy and safety of to …
Currently, topical minoxidil is the only FDA-approved treatment for female AGA and it needs life-long application and causes side effects. …
Improved transdermal delivery of cetirizine hydrochloride using polymeric microneedles.
Arshad MS, Hassan S, Hussain A, Abbas N, Kucuk I, Nazari K, Ali R, Ramzan S, Alqahtani A, Andriotis EG, Fatouros DG, Chang MW, Ahmad Z. Arshad MS, et al. Daru. 2019 Dec;27(2):673-681. doi: 10.1007/s40199-019-00301-3. Epub 2019 Oct 19. Daru. 2019. PMID: 31630328 Free PMC article.
PURPOSE: The aim of this study was to design and characterize microneedle patch formulation containing cetirizine hydrochloride. METHODS: Chitosan was co-formulated with cetirizine hydrochloride. ...Graphical abstract Microneedle patch manifest a two-f …
PURPOSE: The aim of this study was to design and characterize microneedle patch formulation containing cetirizine hydrochloride …
[Cetirizine hepatotoxicity].
Prieto de Paula JM, Franco Hidalgo S, Nalotto L, Ginés Santiago A. Prieto de Paula JM, et al. Med Clin (Barc). 2011 Sep 10;137(6):283-4. doi: 10.1016/j.medcli.2010.09.027. Epub 2010 Dec 8. Med Clin (Barc). 2011. PMID: 21145082 Spanish. No abstract available.
Topical cetirizine for treating androgenetic alopecia: A systematic review.
Chen X, Xiang H, Yang M. Chen X, et al. J Cosmet Dermatol. 2022 Nov;21(11):5519-5526. doi: 10.1111/jocd.15309. Epub 2022 Sep 4. J Cosmet Dermatol. 2022. PMID: 35976065 Review.
Further, cetirizine might be as effective as minoxidil in improving hair diameter. ...In order to fully understand the role of topical cetirizine for AGA, additional well-designed RCTs are needed....
Further, cetirizine might be as effective as minoxidil in improving hair diameter. ...In order to fully understand the role of topica …
The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review.
Blaiss MS, Bernstein JA, Kessler A, Pines JM, Camargo CA Jr, Fulgham P, Haumschild R, Rupp K, Tyler T, Moellman J. Blaiss MS, et al. Adv Ther. 2022 Jan;39(1):178-192. doi: 10.1007/s12325-021-01999-x. Epub 2021 Dec 4. Adv Ther. 2022. PMID: 34862952 Free PMC article. Review.
Since 1955, the only available H(1) antihistamines for intravenous administration have been first-generation formulations and, of those, only intravenously administered (IV) diphenhydramine is still approved in the USA. Orally administered cetirizine hydrochloride, …
Since 1955, the only available H(1) antihistamines for intravenous administration have been first-generation formulations and, of those, onl …
[Pharmacological and clinical properties of cetirizine hydrochloride].
Uchida M, Nakahara H. Uchida M, et al. Nihon Yakurigaku Zasshi. 2000 Apr;115(4):229-35. doi: 10.1254/fpj.115.229. Nihon Yakurigaku Zasshi. 2000. PMID: 10876807 Review. Japanese.
In clinical pharmacological tests, cetirizine markedly reduced wheal and flare responses induced by histamines. ...Cetirizine also inhibited eosinophil chemotaxis in vitro at a concentration easily attained after a clinical dose of 10 mg. ...
In clinical pharmacological tests, cetirizine markedly reduced wheal and flare responses induced by histamines. ...Cetirizine …
Cetirizine-induce cholestasis.
Fong DG, Angulo P, Burgart LJ, Lindor KD. Fong DG, et al. J Clin Gastroenterol. 2000 Oct;31(3):250-3. doi: 10.1097/00004836-200010000-00016. J Clin Gastroenterol. 2000. PMID: 11034010
In U.S. clinical trials, transient reversible hepatic transaminase elevations were observed in <2% of patients during cetirizine therapy. We report a case of cetirizine-induced cholestasis in a 28-year-old man with no previous hepatobiliary disease after a 2-year …
In U.S. clinical trials, transient reversible hepatic transaminase elevations were observed in <2% of patients during cetirizine t …
2,166 results